Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vita-NEM Plus is a combination dietary supplement developed and marketed by AGP in Pakistan for the support of joint and bone health. It is formulated as an oral capsule containing Natural Eggshell Membrane (NEM), cholecalciferol (Vitamin D3), menaquinone-7 (Vitamin K2), and zinc. Natural Eggshell Membrane naturally provides structural proteins and glycosaminoglycans, including collagen, hyaluronic acid, glucosamine, and chondroitin sulfate, which support the cartilage matrix and synovial fluid. The addition of Vitamin D3 and Vitamin K2 regulates calcium homeostasis and bone mineralization, while zinc supports connective tissue integrity and immune function. Vita-NEM Plus is approved and marketed for alleviating arthritis symptoms, reducing joint pain, and managing knee osteoarthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vita-NEM Plus.